|
|
|
28.11.25 - 19:48
|
Multiconsult ASA – Share buy-back programme completed (Cision)
|
|
|
Multiconsult ASA (OSE: MULTI) announced on 24 February 2025 a non-discretionary agreement with DNB Markets, a part of DNB Bank ASA for the repurchase of up to 500 000 of its ordinary shares in the market, with the purpose of meeting obligations arising from Multiconsult's employee share saving programme and executive management bonus schemes. As part of this, a portion of the purchased shares has been used to settle the loan under the share loan agreement with its largest shareholder Stiftelsen Multiconsult. On 29 August 2025, it was further announced that the buy-back programme would include...
|
|
|
27.11.25 - 07:00
|
Atea Receives ESG Transparency Award for Consecutive Year (Cision)
|
|
|
Oslo – Atea has once again received the ESG Transparency Award from EUPD Research, earning the distinguished “Excellence Class” designation for its commitment to transparent reporting. In addition, Atea has achieved the “Leading Companies” status, an honor reserved for top performers within their country, size category, and industry.
Steinar Sønsteby, CEO of Atea, commented: “This recognition reflects our long-standing dedication to clarity and completeness in non-financial reporting. We are pleased that our efforts continue to be ranked among the best in Europe.“
Atea has received...
|
|
|
26.11.25 - 17:36
|
Atea ASA - share buyback (Cision)
|
|
|
Oslo, 26 November 2025
Please see below information about transactions made under the share buyback program for Atea ASA.
Date on which the buyback program was announced: 18 August 2025.
The duration of the buyback program: 18 August 2025 to 30 April 2026, or until the maximum number of shares has been repurchased.
Size of the buyback program: Up to 800,000 shares
From 18 November 2025 until 26 November 2025, Atea ASA has purchased a total of 30,973 own shares at the Oslo Stock Exchange at an average price of NOK 145.26 per share. Following the completion of the above...
|
|
|
25.11.25 - 10:36
|
Atea awarded large contract with the NATO Communication and Information Agency for Managed Devices Service (Cision)
|
|
|
Atea Denmark has been awarded a landmark contract by the NATO Communication and Information Agency (NCIA) to deliver and manage the entire lifecycle of PCs and mobile devices for end users across 32 member countries. The estimated value of the contract is approximately Euro 130 million over four years, with scope for growth as demand increases.
“This contract is more than a delivery - it's a partnership between NATO and Atea,” commented Steinar Sønsteby, Group CEO of Atea. “We are immensely proud to support NATO's mission by ensuring their personnel are equipped with secure, reliable,...
|
|
|
21.11.25 - 19:00
|
Multiconsult ASA – Status on share buy-back (Cision)
|
|
|
Multiconsult ASA (OSE: MULTI) announced on 24 February 2025 a non-discretionary agreement with DNB Markets, a part of DNB Bank ASA for the repurchase of up to 500 000 of its ordinary shares in the market with the purpose to meet obligations arising from Multiconsult's employee share saving programme and executive management bonus schemes. As part of this, a portion of the purchased shares has been used to settle the loan under the share loan agreement with its largest shareholder Stiftelsen Multiconsult. On 29 August 2025, it was further announced that the buy-back programme would comprise a...
|
|
|
19.11.25 - 13:03
|
Atea Pharmaceuticals to Present at the 8th Annual Evercore Healthcare Conference (GlobeNewswire EN)
|
|
|
BOSTON, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that Jean-Pierre Sommadossi, PhD, Chief Executive Officer and Founder of Atea, together with other members of the Atea management team, will participate in a fireside chat at the 8th Annual Evercore Healthcare Conference on Wednesday, December 3, 2025 at 10:00 a.m. ET in Coral Gables, FL....
|
|
|
19.11.25 - 07:06
|
Ex dividend NOK 3.50 today (Cision)
|
|
|
The shares in Atea ASA will be traded ex dividend NOK 3.50 as from today, 19 November 2025.
For further information, please contact:
Steinar Sønsteby, CEO Atea ASA, mobile (+47) 930 55 655
Robert Giori, CFO Atea ASA, mobile (+47) 934 09 188...
|
|
|
|
|
13.11.25 - 10:13
|
HomeToGo: Anleihedebüt mit Nordic Bond ante portas? (BondGuide)
|
|
|
Die HomeToGo SE lanciert Anleihedebüt im Nordic-Bond-Format: Danach sondiere die Online-Plattform für Ferienunterkünfte die Emission eines nicht nachrangigen, besicherten Floaters 2025/30 im anfänglichen Gesamtnennbetrag von bis zu 150 Mio. EUR. Hierfür habe die HomeToGo SE ABG Sundal Collier und Pareto Securities, Frankfurt Branch, als Global Coordinators und Joint Bookrunner sowie die UniCredit Bank als Co-Lead […]...
|
|
|
|
|
|
|
12.11.25 - 19:01
|
Multiconsult ASA – Status on share buy-back (Cision)
|
|
|
Multiconsult ASA (OSE: MULTI) announced on 24 February 2025 a non-discretionary agreement with DNB Markets, a part of DNB Bank ASA for the repurchase of up to 500 000 of its ordinary shares in the market with the purpose to meet obligations arising from Multiconsult's employee share saving programme and executive management bonus schemes. As part of this, a portion of the purchased shares has been used to settle the loan under the share loan agreement with its largest shareholder Stiftelsen Multiconsult. On 29 August 2025, it was further announced that the buy-back programme would comprise a...
|
|
|
|
|
11.11.25 - 07:30
|
Nordhealth AS: Q3/2025 results presentation (Cision)
|
|
|
Please find attached the presentation of Nordhealth AS Q3/2025 results.
The results will be presented in a live webcast and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 11th of November 2025 at 15:00 CET.
Please use the following link to attend: https://us02web.zoom.us/j/82347752551
The presentation will be recorded and made available on www.nordhealth.com
For further information, please contact:
Charles MacBain, CEO
charles.macbain@nordhealth.com
+44 75 3903 2200
Alexander Cram, CFO
alexander.cram@nordhealth.com
+32 470 69 30 20...
|
|
|
11.11.25 - 07:01
|
Webstep ASA: Third quarter results 2025 (Cision)
|
|
|
Oslo, 11 November 2025: Webstep ASA today reports revenues of NOK 178.3 million (189.4) for the third quarter 2025, a decrease of 5.8 per cent from the same period last year. EBIT was NOK 8.2 million, corresponding to an EBIT margin of 4.6 per cent (5.7).
The decline in revenues reflects a reduced number of consultants, partly due to the discontinuation of non-core activities and reduced utilisation, amid the challenging market.
“Looking back at the first nine months of 2025, I am genuinely proud of our team's effort and the strong results delivered. We have strengthened Webstep's...
|
|
|
|
|
06.11.25 - 11:42
|
Mandatory notification of trade – primary insider (Cision)
|
|
|
The following primary insider in Multiconsult ASA has purchased shares in Multiconsult ASA:
Rikard Appelgren, chair of the board of directors in Multiconsult ASA has on 6 November 2025 purchased 5 000 shares in Multiconsult ASA at an average price of NOK 167.00 per share and will after the transaction hold 50 000 shares in Multiconsult ASA.
For further information, please contact:
Investor relations:
Pål-Sverre Jørgensen, Group Treasurer & Investor Relations Officer
Phone: +47 416 11 161
E-mail: ir@multiconsult.no / psmj@multiconsult.no
This information is subject to the...
|
|
|
05.11.25 - 21:37
|
Nordhealth AS - Invitation to Q3 2025 presentation (Cision)
|
|
|
Nordhealth will report and present its Q3 2025 results on Tuesday the 11[th] of November 2025.
The results will be presented in a live presentation and subsequent Q&A session with CEO Charles MacBain and CFO Alexander Cram on the 11[th] of November at 15:00 CET.
Please use the following link to attend: https://us02web.zoom.us/j/82347752551
The presentation will be recorded and made available on www.nordhealth.com. The presentation material for Q3/2025 will be available on 11[th] November 2025 at 07:30 CET on www.newsweb.no (https://publish.ne.cision.com/l/afkpudtpe/www.newsweb.no)...
|
|
|
05.11.25 - 13:03
|
Atea Pharmaceuticals to Host Third Quarter 2025 Financial Results and Business Update Conference Call on November 12, 2025 (GlobeNewswire EN)
|
|
|
BOSTON, Nov. 05, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. (Nasdaq: AVIR) (Atea or Company), a clinical-stage biopharmaceutical company engaged in the discovery and development of oral antiviral therapeutics for serious viral diseases, today announced that it will host a live conference call and audio webcast on Wednesday, November 12, 2025, at 4:30 p.m. ET to report financial results for the third quarter ended September 30, 2025, and to provide a business update....
|
|
|
05.11.25 - 07:06
|
Norconsult to acquire Metier Group AS (Cision)
|
|
|
Sandvika, 5 November 2025 (OSE: NORCO): Norconsult ASA (“Norconsult”) has entered into a definitive agreement to acquire 100% of the shares of Metier Group AS (“Metier”), a leading Norwegian consultancy specialized in project management, business development, digitalisation and educational programs from Tetra Tech RPS Energy Limited.
Metier is headquartered in Oslo and has 250 employees. The company serves a broad and diverse client base across both public and private customers. Metier has a strong brand and a solid reputation in the Norwegian market.
For the twelve-month period...
|
|
Börsentreff auf Facebook |
Börsentreff auf X |
Börsentreff auf Instagram
